Biosynex SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biosynex SA with three other
companies in this sector in FRANCE :
sales of 13.14 million Euro [US$14.33 million]
of which 100%
was research and development of epicutaneous),
Eurobio Scientific SA
(59.10 million Euro [US$64.45 million]
(8.45 million Euro [US$9.21 million]
During the year ended December of 2019, sales at
Biosynex SA were 34.23 million Euro (US$37.33 million).
increase of 9.7%
versus 2018, when the company's sales were 31.21 million Euro.
This was the fifth consecutive year of sales increases at Biosynex SA
(and since 2014, sales have increased a total of 740%).
Sales of Services saw an increase
that was more than double the company's growth rate: sales were up
325.8% in 2019, from
281,328.00 Euro to 1.20 million Euro.